December 14, 2024 03:49 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
UN health agency to examine lower-cost ‘biosimilar’ drugs to expand access to cancer treatment

UN health agency to examine lower-cost ‘biosimilar’ drugs to expand access to cancer treatment

May 05, 2017, at 09:33 pm

New York, May 5 (Just Earth News): As a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries, the World Health Organization (WHO) said on Thursday that it will launch a pilot project for prequalifying so-called “biosimilars,” or lower cost drugs.